Revolutionize Precision Medicine

We unravel disease mechanisms
by identifying aberrant activities
of cell signaling pathways

news

InnoSIGN aims to increase survival rates of cancer patients using PCR tests

events

The use of ribociclib/letrozole combination as an alternative for neoadjuvant chemotherapy

events

High HH and low AR associated with resistance to ARDT in prostate cancer